IQVIA director gets 158 deferred shares at $210.12; holds 2,772
IQVIA Holdings (IQV): Director Form 4 update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IQVIA Holdings (IQV): Director Form 4 update. Director John G. Danhakl reported acquiring 158 deferred shares on 11/05/2025 at a price of $210.12 per unit. Following this transaction, he beneficially owned 2,772 derivative securities.
These deferred shares convert into one share of IQVIA common stock upon settlement. Under the company’s Non-Employee Director Deferral Plan, settlement occurs when the director leaves the board, upon a change in control of the company, or upon the director’s death. The deferred shares have no expiration date. Ownership is reported as direct.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 158 | $210.12 | $33K |
Footnotes (1)
- F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did IQV (IQVIA) disclose in this Form 4?
How many derivative securities does the director hold after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.